Elevance Health Stock Soars 7.62%, Hits Intraday High of $416.26

Elevance Health, Inc. has experienced a significant uptick in its stock performance, gaining 7.62% on July 1, 2026. The stock reached an intraday high of USD 416.26, showcasing notable activity in the healthcare services sector. This performance stands in contrast to the S&P 500, which saw a slight decline of 0.22% on the same day. Over the past week, Elevance Health has shown a robust increase of 8.38%, while its monthly performance reflects a gain of 3.36%. Year-to-date, the stock has risen by 18.72%, outperforming the S&P 500's 9.32% increase. However, it is important to note that the stock has faced challenges over the longer term, with a three-year performance decline of 6.32% compared to the S&P 500's impressive 68.15% growth. Elevance Health's market capitalization stands at USD 63,208 million, and it maintains a price-to-earnings ratio of 11.00. The company also offers a dividend yield of 2.46%. Despite some fluctuations in performance metrics, Elevance Health continues to be a significant player in the healthcare services industry.